Robot assisted gynaecological surgery is exponentially expanding its field and gynaecologists need to be prepared to implement this new approach in clinical practice.

Epilepsy has a worldwide prevalence of about 50 million [1]. Seizure medications provide adequate control in two thirds of these patients but about a third are refractory to multiple medications and need surgery or other treatments [2].

The World Health Organisation (WHO) defines anaemia as a haemoglobin (Hb) of less than 130 mg/mL in men and 120 mg/mL in non-pregnant women. Anaemia has a global prevalence of 25%. In patients presenting for surgery the prevalence can be as high as 40%. Anaemia can be acute or chronic; but becomes problematic when there are insufficient numbers of red blood cells to maintain physiological oxygen demand, the end result being compromised oxygen delivery.

Using robots in surgeries dates back to the mid-1980s. The robotic was applied in a wide range of biological and medical sciences such as clinical medicine, neuroscience, cardiovascular, dentofacial, and cellular and molecular life sciences. Orthopedic robots are much more widely used and complex in medical engineering sciences. 

Our recently published research article “Vγ2⁺ γδ T cells in the presence of anti-CD40L control surgical inflammation and promote skin allograft survival” revealed that the Vγ2⁺ subset of γδ T cells, which otherwise are known primarily for its proinflammatory function, regulate the survival of skin allografts in the presence of anti-CD40L.